1-11 of 11
Maria Baer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Contact-free single cell assay for assessing RBC mechanical properties using brillouin microscopy: Evaluation of anti-sickling therapeutics

Free
Aishwarya Anand, Yogeshwari Ambekar, Stephen Rogers, Ashlee Conway, Maria Baer, Jennie Law, Ashlyn Poland, Tobi Rowden, Saini Setua, Regina Adao, Zohreh Safari, Deanna Pineiro, Mary Brummet, Daniel Bennett, Shraddha Krishnakumar, Andre Vlies, Dipanjan Pan, Giuliano Scarcelli, Allan Doctor
Journal: Blood
Blood (2025) 146 (Supplement 1): 6490.
https://doi.org/10.1182/blood-2025-6490
Published: 2025
Journal Articles

Results of the APG2575AU101 Study of lisaftoclax (APG-2575) combined with azacitidine (AZA) in patients with newly diagnosed (ND) or prior venetoclax–exposed myeloid malignancies

Free
Tapan Kadia, Patricia Kropf, Michael Leahy, Chong Chyn Chua, Shaun Fleming, Caspian Oliai, John Kwan, Chun Yew Fong, Joshua Richmond, Paul Cannell, James Dugan, Maria Baer, Stephen Ting, Daniel Egan, Zi Chen, Qian Niu, Mingyu Li, Divya Mekala, Zhiyan Liang, Mohammad Ahmad, Yifan Zhai
Journal: Blood
Blood (2025) 146 (Supplement 1): 1641.
https://doi.org/10.1182/blood-2025-1641
Published: 2025
Journal Articles

Phase 1b safety run-in study followed by Phase 2 study of ficlatuzumab, azacitidine and venetoclax in untreated Acute Myeloid Leukemia patients aged ≥ 60 years old

Free
Emily Curran, Ying Huang, Shivani Handa, Ronan Swords, Eytan Stein, Maria Baer, Wendy Stock, Yazan Madanat, Rebecca Olin, William Blum, Gary Schiller, Tara Lin, Joshua Zeidner, Bradley Blaser, Molly Martycz, Leonard Rosenberg, Sonja Marcus, Timothy Chen, Mona Stefanos, Ashley Yocum, Ross Levine, Brian Druker, Uma Borate, Alice Mims, John Byrd
Journal: Blood
Blood (2025) 146 (Supplement 1): 3432.
https://doi.org/10.1182/blood-2025-3432
Published: 2025
Journal Articles

Venetoclax (VEN) and azacitidine (AZA) with gilteritinib (GILT) in patients with newly diagnosed (ND) FLT3mut+ Acute Myeloid Leukemia (AML) ineligible for intensive induction chemotherapy (chemo): Interim results from the phase 1/2 VICEROY study

Free
Jessica Altman, Alexander Perl, Eunice Wang, Uma Borate, Elie Traer, James Dugan, Margaret Kasner, Richard Larson, Yehuda Deutsch, Aditi Shastri, Maria Baer, Steven Tsai, Deepa Jeyakumar, Hoda Pourhassan, Alireza Eghtedar, Caroline Chen, Alexandra Heinloth, Rishita Nuthethi, Stanley Gill, Jason Hill, Nahla Hasabou, Mark Levis, Naval Daver
Journal: Blood
Blood (2025) 146 (Supplement 1): 654.
https://doi.org/10.1182/blood-2025-654
Published: 2025
Journal Articles

Next generation sting agonist in combination with DNA methyltransferase inhibitors induce an apoptotic cell death mechanism driven by apoptosis in TP53-mutated Acute Myeloid Leukemia

Free
Lora Stojanovic, Kaushlendra Tripathi, Monali Banerjee, Arjun Surya, Stephen Baylin, Michael Topper, Maria Baer, Feyruz Rassool
Journal: Blood
Blood (2025) 146 (Supplement 1): 3233.
https://doi.org/10.1182/blood-2025-3233
Published: 2025
Journal Articles

Prognostic risk integration for survival modeling (PRISM) in newly diagnosed acute myeloid leukemia treated with venetoclax:  a multinational retrospective cohort study

Free
Curtis Lachowiez, Andy Kaempf, Jad Othman, Seongseok Yun, Mael Heiblig, Michael Heuser, Rabia Shahswar, Anand Patel, Rafael Madero-Marroquin, Joseph Cannova, Irene Zacheo, Federica Monaco, Dimitrios Drekolias, Fatima Tuz Zahra, Amine Belhabri, Urbain Tauveron-Jalenques, Emmanuelle Tavernier, Martin Carre, Gaspar Aspas Requena, Nicola Long, Rachel Cook, Elie Traer, Ronan Swords, Jennifer Saultz, Jenny O'Nions, Faisal Basheer, John Laurie, Shivani Handa, Eytan Stein, Maria Baer, Wendy Stock, Rebecca Olin, William Blum, Gary Schiller, Tara Lin, Emily Curran, Ying Huang, Rina Welkie, Ashley Yocum, Giovanni Marconi, Ellen Madarang, Justin Watts, Yazan Madanat, Richard Dillon, Sanam Loghavi, Joshua Zeidner, Daniel Pollyea, Elsa Bernard
Journal: Blood
Blood (2025) 146 (Supplement 1): 453.
https://doi.org/10.1182/blood-2025-453
Published: 2025
Journal Articles

Initial results from a phase 2 study of cladribine, cytarabine, and granulocyte-colony stimulating factor with gemtuzumab ozogamicin (CLAG-GO) for the treatment of patients with relapsed/refractory acute myeloid leukemia

Free
David Chen, Maria Baer, Sandrine Niyongere, Ashkan Emadi, Vivek Shastri, Jatinder Lamba, Michael Loken, Larissa Sanglard, Rena Lapidus, Soren Bentzen, Vu Duong
Journal: Blood
Blood (2025) 146 (Supplement 1): 999.
https://doi.org/10.1182/blood-2025-999
Published: 2025
Journal Articles

RAS mutations negate the favorable impact of NPM1 in older patients with newly diagnosed Acute Myeloid Leukemia treated with ven/HMA

Free
Fieke Hoff, Alexander Li, Ying Huang, Rina Welkie, Ronan Swords, Elie Traer, Eytan Stein, Tara Lin, Maria Baer, Vu Duong, William Blum, Martha Arellano, Wendy Stock, Olatoyosi Odenike, Joshua Zeidner, Rebecca Olin, Catherine Smith, Gary Schiller, Emily Curran, Shivani Handa, Nyla Heerema, Timothy Chen, Molly Martycz, Mona Stefanos, Sonja Marcus, Leonard Rosenberg, Brian Druker, Ross Levine, Ashley Yocum, Uma Borate, Alice Mims, John Byrd, Yazan Madanat
Journal: Blood
Blood (2025) 146 (Supplement 1): 995.
https://doi.org/10.1182/blood-2025-995
Published: 2025
Journal Articles

Sphingosine-1-phosphate receptor modulators overcome FLT3 inhibitor resistance in Acute Myeloid Leukemia with FLT3-ITD and NRAS mutations through sphingosine kinase 1/AKT pathway downregulation.

Free
Aditi Chatterjee, Moaath Mustafa Ali, Christopher Bailey, Yuchen Liu, Donald Small, Catherine Smith, Elie Traer, Yin Wang, Giovannino Silvestri, Maria Baer
Journal: Blood
Blood (2025) 146 (Supplement 1): 3288.
https://doi.org/10.1182/blood-2025-3288
Published: 2025
Journal Articles

Challenges for Conducting Clinical Trials Evaluating Maintenance Chemotherapy In Acute Myeloid Leukemia (AML): a Cancer and Leukemia Group B (CALGB) Study

Free
William Blum, MD, Kate Donohue, PhD, Guido Marcucci, MD, Daniel J DeAngelo, MD, PhD, Geoffrey L Uy, MD, Bayard L Powell, MD, Wendy Stock, MD, Maria Baer, MD, Jonathan E Kolitz, MD, Meir Wetzler, MD, Eva Hoke, Barry K Moser, PhD, Richard A Larson, MD
Journal: Blood
Blood (2010) 116 (21): 2176.
https://doi.org/10.1182/blood.V116.21.2176.2176
Published: 2010
Journal Articles

Rapamycin Causes Reversible Cell Cycle Slowing, Rather Than Cell Cycle Arrest, in Myeloid and Lymphoid Cell Lines and in Acute Leukemia Cells

Free
Amy Kimball, MD, PhD, Mehmet Burcu, BS, Kieran L O’Loughlin, MS, Laurie A. Ford, Hans Minderman, Maria Baer
Journal: Blood
Blood (2008) 112 (11): 5021.
https://doi.org/10.1182/blood.V112.11.5021.5021
Published: 2008